Neuropeptides and Central Nervous System Injury
- 1 May 1986
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 43 (5), 501-504
- https://doi.org/10.1001/archneur.1986.00520050073026
Abstract
• It has been proposed that endogenous opioids play a pathophysiologic role in the secondary injury that follows spinal trauma, brain trauma, and cerebral ischemia. Opiate antagonists, at high doses, have been found to improve outcome in various experimental models of central nervous system injury. Thyrotropinreleasing hormone, which appears to act in part as a functional antagonist of opioid systems, has proved effective in the treatment of experimental spinal cord and brain trauma. The literature relating to these developments is reviewed, with emphasis on the potential clinical application of these classes of substances.Keywords
This publication has 38 references indexed in Scilit:
- Opiate antagonist WIN44, 441–3 stereospecifically improves neurologic recovery after ischemic spinal injuryNeurology, 1985
- Opiate antagonists and thyrotropin-releasing hormone. II. Potential role in the treatment of central nervous system injuryPublished by American Medical Association (AMA) ,1984
- Brain Peptides: What, Where, And Why?Science, 1983
- Nonopioid Neuropeptides in Mammalian CNSAnnual Review of Pharmacology and Toxicology, 1983
- Endorphins in experimental spinal injury: Therapeutic effect of naloxoneAnnals of Neurology, 1981
- Opiate Antagonist Improves Neurologic Recovery After Spinal InjuryScience, 1981
- Endorphin-parasympathetic interaction in spinal shockJournal of the Autonomic Nervous System, 1980
- Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shockBrain Research, 1980
- Opiate Antagonists: A Role in the Treatment of Hypovolemic ShockScience, 1979
- Naloxone reversal of endotoxin hypotension suggests role of endorphins in shockNature, 1978